Rho's blog

Adaptive Designs in Pharmaceutical Research

Join Karen Kesler, one of Rho's experts in Adaptive Designs, as she reflects on the current state of Adaptive Designs in pharmaceutical research. She'll cover topics such as FDA preferences, regulatory concerns, biostatistical considerations, and protocol implementation logistics. We look forward to hearing from you as we discuss and shape this emerging field together.

Karen Kesler, [Full Profile]

All comments submitted to the Rho's blog are reviewed by a moderator prior to posting. Rho has developed the following guidelines to determine which comments will be posted. Rho is committed to posting all comments that further discussion related to topics contained in this blog and encourage reasonable, professional disagreement and debate; however, Rho retains the right to not post, delete or edit any comment at our sole discretion.
Click here for full details